A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes

NCT03689374 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2274

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Semaglutide
DRUG: Insulin aspart
DRUG: Insulin glargine U100

Sponsor

Novo Nordisk A/S